![Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-018-1175-8/MediaObjects/12974_2018_1175_Fig6_HTML.gif)
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
![PDF) Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease | Jadwiga Wardas - Academia.edu PDF) Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease | Jadwiga Wardas - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47314721/mini_magick20190207-2593-1tey8fj.png?1549546815)
PDF) Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease | Jadwiga Wardas - Academia.edu
![IJMS | Free Full-Text | Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats IJMS | Free Full-Text | Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats](https://pub.mdpi-res.com/ijms/ijms-19-02242/article_deploy/html/images/ijms-19-02242-ag-550.jpg?1570328741)
IJMS | Free Full-Text | Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats
![Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model](https://www.frontiersin.org/files/Articles/473589/fnins-13-00839-HTML/image_m/fnins-13-00839-g001.jpg)
Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
![DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice](https://www.spandidos-publications.com/article_images/mmr/17/3/MMR-17-03-3884-g01.jpg)
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice
![Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41401-022-00951-1/MediaObjects/41401_2022_951_Fig1_HTML.png)
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica
![IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models](https://pub.mdpi-res.com/ijms/ijms-18-02043/article_deploy/html/images/ijms-18-02043-ag-550.jpg?1569561566)
IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models
![Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666354620300259-gr3.jpg)
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
![MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease - Lv - 2021 - Journal of Neurochemistry - Wiley Online Library MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease - Lv - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3fc6ab3b-a2ed-410c-bd4a-583b6cac0331/jnc15299-fig-0009-m.jpg)
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease - Lv - 2021 - Journal of Neurochemistry - Wiley Online Library
![Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease | Semantic Scholar Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bee1dcfbcbae8bfac7485b47914c665fc96a8360/6-Figure1-1.png)
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease | Semantic Scholar
![Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666354620300259-gr1.jpg)
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
![Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons](https://static-02.hindawi.com/articles/isrn/volume-2011/476158/figures/476158.fig.002.jpg)
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
![PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons](https://www.researchgate.net/profile/Sandro-Argueelles/publication/221887535/figure/fig2/AS:203178546077698@1425452948203/Interaction-between-glia-and-neurons-may-lead-to-neuron-damage-and-death-LPS-activates_Q320.jpg)
PDF) Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation | ACS Pharmacology & Translational Science
![Parkinson's disease: Are gut microbes involved? | American Journal of Physiology-Gastrointestinal and Liver Physiology Parkinson's disease: Are gut microbes involved? | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00058.2020/asset/images/medium/gi-00058-2020r01.png)
Parkinson's disease: Are gut microbes involved? | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens | bioRxiv Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/05/24/646307/F1.large.jpg)
Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens | bioRxiv
![PDF) Further characterisation of the LPS model of Parkinson's disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. | Pádraig Mulcahy - PDF) Further characterisation of the LPS model of Parkinson's disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. | Pádraig Mulcahy -](https://0.academia-photos.com/attachment_thumbnails/30432818/mini_magick20190426-1108-1d2shq7.png?1556333913)